Results 41 to 50 of about 10,701 (213)

What is the Oregon Psilocybin Services Act?. Spanish

, 2022
An overview of the Oregon Psilcoybin Services Act (ORS 475A).This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Eating disorders (EDs) are characterized by high rates of psychiatric comorbidity and suboptimal treatment outcomes. There remain critical gaps in research, including the exploration of effective transdiagnostic interventions. This forum article examines the potential of psilocybin treatment (PT) as a transdiagnostic intervention for
Elena Koning, Jérémie Richard, Aaron Keshen   +2 more
wiley   +1 more source

Kan psilocybin minska depressionssymtom

, 2021
Introduktion: Depression är en vanlig psykisk sjukdom som påverkar patientenslivskvalitet negativt. Symtomatisk kan depression orsaka att patienten känna sig ledsen,orolig, tom, hopplös, rastlös och ännu allvarligare kan depressiva patienter försökaeller 
Bator, Elena
core   +2 more sources

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder

Translational Psychiatry, 2021
Psilocybin has shown promise for the treatment of mood disorders, which are often accompanied by cognitive dysfunction including cognitive rigidity.
Manoj K. Doss, Michal Považan, Monica D. Rosenberg, Nathan D. Sepeda, Alan K. Davis, Patrick H. Finan, Gwenn S. Smith, James J. Pekar, Peter B. Barker, Roland R. Griffiths, Frederick S. Barrett   +10 more
doaj   +1 more source

A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol

European Psychiatry, 2023
Introduction During the last decade there has been a resurgence of interest on the use of psychedelics as novel treatments for mental disorders, including treatment-resistant depression (TRD). Psilocybin, the chemical component of “magic mushrooms”, has
M. I. Husain, D. M. Blumberger, D. J. Castle, S. M. Kloiber, A. Ortiz, J. D. Rosenblat, B. H. Mulsant   +6 more
doaj   +1 more source

Comprehensive Review on Advancements in Food Preservation Technologies for Quality and Sustainability

Food Chemistry International, EarlyView.
Preservatives limit microbial development, oxidation, and enzymatic degradation, resulting in better food quality and extended shelf life. Classified as natural, synthetic, or biological, each preservative has distinctive attributes and modes of action. Growing preference for natural preservatives aligns with clean label trends.
Monica Suresh, Arun Meyyazhagan, Haripriya Kuchi Bhotla, Manikantan Pappuswamy, Balamuralikrishnan Balasubramanian   +4 more
wiley   +1 more source

Neuroprotective effects of psilocybin in a rat model of stroke

BMC Neuroscience
Background Psilocybin is a psychedelic 5HT2A receptor agonist found in “magic mushrooms”. Recent studies have indicated that 5HT2A agonists, such as dimethyltryptamine, given before middle cerebral artery occlusion (MCAo), improve staircase behavior ...
Seong-Jin Yu, Kuo-Jen Wu, Yu-Syuan Wang, Eunkyung Bae, Fabio Chianelli, Nicholas Bambakidis, Yun Wang   +6 more
doaj   +1 more source

"A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.

PLoS ONE, 2022
ObjectivesPeople with bipolar disorder (BD) spend more time depressed than manic/hypomanic, and depression is associated with greater impairments in psychosocial functioning and quality of life than mania/hypomania. Emerging evidence suggests psilocybin,
Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley, Erin Michalak   +6 more
doaj   +1 more source

Transdiagnostic and symptom‐domain associations between mental illnesses and future self‐connectedness versus future self‐valence

JCPP Advances, EarlyView.
Abstract Background Future time perspective dimensions have been linked to various mental illnesses. Given the tendency for mental illnesses to co‐occur, it is necessary to disentangle associations between future‐oriented constructs and shared versus symptom‐domain‐specific psychopathology.
Yi Yang, Ingrid Obsuth, Jean‐Louis van Gelder, Denis Ribeaud, Manuel Eisner, Xinxin Zhu, Aja Louise Murray   +6 more
wiley   +1 more source

Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report

Frontiers in Psychiatry
Psilocybin has reemerged as a promising treatment for difficult-to-treat depression (DTD). Although there is limited evidence regarding interactions between psilocybin and other psychotropic drugs, clinical trials require that patients discontinue their ...
André Do, Vanessa Michaud, Jean-François Stephan, Miltiadis Moreau, Élise Benoît, Félix-Antoine Bérubé, Antoine Bibaud-De Serres, Alain Taillefer, Philippe Vincent, Philippe Vincent   +9 more
doaj   +1 more source